Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Scribe Therapeutics Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Scribe Therapeutics Inc. filed amended and restated Certificate of Incorporation and Bylaws with Delaware on July 27, 2026, effective upon closing of its IPO. This routine corporate governance update reflects the company's transition to public company status and compliance with securities regulations.
Key Takeaways
Company completed its initial public offering on July 27, 2026, with final prospectus dated July 23, 2026
Amended and Restated Certificate of Incorporation and Bylaws were approved by board and stockholders and became effective at IPO closing
2 more takeaways